Hologic has been granted a patent for a system that delivers radiofrequency power to the endometrial lining tissue of a uterine cavity. The system modulates power to ensure the tissue impedance matches a target impedance over time, improving endometrial lining tissue ablation. GlobalData’s report on Hologic gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Hologic Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Hologic, Image segmentation techniques was a key innovation area identified from patents. Hologic's grant share as of February 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.

System for ablating endometrial lining tissue using radiofrequency power

Source: United States Patent and Trademark Office (USPTO). Credit: Hologic Inc

A recently granted patent (Publication Number: US11918276B2) discloses a system for ablating endometrial lining tissue using radiofrequency (RF) technology. The system includes an RF applicator, an RF generator, and a controller with a tissue impedance measurement circuit and a power modulation module. The controller is designed to deliver RF power to the tissue in a way that the impedance of the tissue matches a target tissue impedance over time. The RF applicator features an electrode carrier with one or more bipolar electrode pairs for effective tissue ablation.

The system's controller determines the target impedance of the endometrial lining tissue based on a preexisting tissue ablation impedance curve and adjusts the delivery of RF power accordingly. The system is capable of modulating the RF power delivery to the tissue until the impedance reaches a target maximum or a set completion time is achieved. The method involves delivering RF power to the tissue within the uterine cavity and adjusting the power delivery to ensure the impedance tracks the target impedance curve. The system aims to provide a precise and controlled approach to endometrial tissue ablation, enhancing the effectiveness and safety of the procedure.

To know more about GlobalData’s detailed insights on Hologic, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.